EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Budi Starch & Sweetener Tbk (BUDI) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Budi Starch & Sweetener Tbk IDR 412, price IDR 226, upside +82.5%, quality 42 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Consumer Defensive · ID · ISIN ID1000084908

BS Thin data Sep 24, 2026

Budi Starch & Sweetener Tbk

BUDI · JK

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value 412.43 IDR · Strongly undervalued (+82%)
!Quality 42/100
!Expensive Growth (revenue 5y +5.9 %/yr)
!Thin margins · 3.6% net margin (TTM)
!Low debt · negative free cash flow
✓Ranks above peers (8/13)
!Narrow moat 34/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

272.57 IDR 85.80 IDR Fair Value 412.43 IDR Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 85.80 IDR – 272.57 IDR · fair‑value band 288.70 IDR – 536.17 IDR · the 226.00 IDR price screens below the 412.43 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Budi Starch & Sweetener Tbk in your weekly email

Every Wednesday you see whether Budi Starch & Sweetener Tbk is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

PT Budi Starch & Sweetener Tbk, together with its subsidiaries, manufactures and sells tapioca and modified tapioca starch, sweeteners, plastic packaging, sulfuric acid, and other chemicals in Indonesia and internationally. The company operates through the Tapioca Starch, Sweeteners, Sulfuric Acid and Other Products, and Plastic Packaging segments.

Show more

PT Budi Starch & Sweetener Tbk, together with its subsidiaries, manufactures and sells tapioca and modified tapioca starch, sweeteners, plastic packaging, sulfuric acid, and other chemicals in Indonesia and internationally. The company operates through the Tapioca Starch, Sweeteners, Sulfuric Acid and Other Products, and Plastic Packaging segments. It offers tapioca flour; glucose and fructose; maltodextrin; plastic sacks; and sulfuric acid. The company was formerly known as PT Budi Acid Jaya Tbk and changed its name to PT Budi Starch & Sweetener Tbk in July 2013. PT Budi Starch & Sweetener Tbk was founded in 1979 and is headquartered in Jakarta Selatan, Indonesia.

Stock analysis

Budi Starch & Sweetener Tbk (BUDI) currently trades at 226.00 IDR, while our model-based Fair Value estimate is 412.43 IDR, implying the stock looks roughly 45.2% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 510.78 IDR per share, and 13 of the 14 models we run sit above the 226.00 IDR price.

Bear case: the Asset-Based group reads lowest at 231.44 IDR, and 1 of the 14 models stay below the price. Evidence for this calculation is low.

Scenario range: 288.70 IDR (bear) to 536.17 IDR (bull), the price of 226.00 IDR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Consumer Defensive sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Budi Starch & Sweetener Tbk reported revenue of 3.2T IDR in FY2025 versus 3.4T IDR in FY2021, a compound −1.5%/yr. Reported net income was 107B IDR in FY2025, compounding +6.4%/yr from FY2021.

Key figures

Market cap 1.0T IDR (≈ $56.8M) · P/E ratio 8.3 · P/S ratio 0.28 · EPS (TTM) 27.21 IDR · Net margin 3.4% · Return on equity 7.8% · Return on assets (EBIT) 6.6% · Operating margin 7.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 35 out of 100 (medium confidence).

What moves the price

The share trades about 5% below its 52-week high and 13% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −3% fair-value upside, at 82%, BUDI screens cheaper than that median.

Fair Value models

Bear 288.70 IDR Fair Value 412.43 IDR Bull 536.17 IDR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (19.98 IDR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Owner Earnings 357.80 IDR 510.78 IDR 690.79 IDR 77
Residual Income 250.46 IDR 252.05 IDR 235.45 IDR 76
EPV 201.58 IDR 240.27 IDR 271.67 IDR 74
All 14 models by family
DCF Models
Owner Earnings 357.80 IDR 510.78 IDR 690.79 IDR 77
Earnings-Based
Graham-Dodd 161.32 IDR 406.87 IDR 528.50 IDR 65
PEG = 1.0 75.06 IDR 107.23 IDR 139.40 IDR 57
EPV 201.58 IDR 240.27 IDR 271.67 IDR 74
Multiples
P/E Multiple 373.65 IDR 498.20 IDR 622.75 IDR 63
P/S Multiple 302.48 IDR 403.30 IDR 504.13 IDR 58
P/B Multiple 302.48 IDR 403.30 IDR 504.13 IDR 55
EV/EBIT 518.62 IDR 731.76 IDR 944.91 IDR 65
EV/EBITDA 764.46 IDR 1,060 IDR 1,355 IDR 67
EV/Revenue 335.56 IDR 531.15 IDR 726.75 IDR 53
Asset-Based
NCAV (Graham) 172.72 IDR 231.44 IDR 345.43 IDR 54
Economic Profit
Residual Income 250.46 IDR 252.05 IDR 235.45 IDR 76
ROIC Compounder 201.58 IDR 240.27 IDR 271.67 IDR 72
Growth Earnings
Growth-Adj P/E 288.70 IDR 412.43 IDR 536.17 IDR 67

Open the full fair value analysis →

Notify me when BUDI reaches fair value

Put BUDI on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 42/100

Of which business quality 38 · Market factors (momentum, volatility) 63

Profitability 32
Margins and returns on capital today
Quality Growth 47
Are margins and returns improving?
Cashflow 3
Earnings quality: real cash, not paper profit
Fin. Strength 28
Balance sheet, leverage, solvency risk
Investment 71
Disciplined investing over empire-building
Low Volatility 91
Calm price path (market factor)
Momentum 51
Price trend over the last 3–12 months (market factor)
52W Momentum 54
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 39/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.9%
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.6%
What shareholders gained per year (last 5 years), in IDR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+11.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+11.3%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.11% vs 13%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 7%
Start year 2020 (pandemic)

Watch BUDI, get fair value alerts →

Compare Budi Starch & Sweetener Tbk with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 666 stocks

Beats the industry median on 8/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 42 · Bottom 25%
Fair Value upside +81% · Top 25%
Profitability
Return on equity (TTM) 8% · Above median
Return on assets 4% · Below median
Net margin (TTM) 4% · Below median
Operating margin (TTM) 8% · Above median
Growth and dividend
Revenue growth 29% · Top 25%
Dividend yield (TTM) 0.0% · Bottom 25%
Balance sheet
Debt / equity 0.44× · Highest 25%

Valuation Multiplesvs Packaged Foods median · lower = cheaper

P/E (TTM) 8.3× · Cheapest 25%
P/B 0.66× · Cheapest 25%
P/S (TTM) 0.30× · Cheaper than median
EV/EBITDA 3.6× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 30
FUTURE (revenue growth)100 · sector 20
PAST (return on equity)31 · sector 29
HEALTH (low debt)78 · sector 96
DIVIDEND (yield)0 · sector 58

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Nestlé S.A NESN CHF 77.09 CHF 59.49 −23%
Danone S.A BN €60.14 €50.81 −16%
The Kraft Heinz Company KHC $23.79 $29.20 +23%
Foshan Haitian Flavouring and Food Company 603288 ¥34.29 ¥37.72 +10%
Nestlé India Limited NESTLEIND ₹1,387 ₹724.74 −48%
Inner Mongolia Yili Industrial Group 600887 ¥26.77 ¥41.84 +56%
Yihai Kerry Arawana Holdings 300999 ¥25.12 ¥9.98 −60%
General Mills, Inc GIS $35.82 $34.66 −3%
Uni-President Enterprises Corp 1216 74.50 TWD 68.72 TWD −8%
McCormick & Company MKC $49.09 $51.01 +4%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Budi Starch & Sweetener Tbk Fair Value". https://www.fairvalue-calculator.com/stock/BUDI

Frequently asked questions

Is Budi Starch & Sweetener Tbk (BUDI) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 412.43 IDR versus a price of 226.00 IDR, about +82% upside (undervalued).
What is the fair value of BUDI?
Our model-based fair value for Budi Starch & Sweetener Tbk is 412.43 IDR (as of Sep 24, 2026), built from audited fundamentals. The current price: 226.00 IDR.
What is the quality score of BUDI?
Budi Starch & Sweetener Tbk has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Budi Starch & Sweetener Tbk (BUDI)?
Our model-based price target is the fair value of 412.43 IDR (as of Sep 24, 2026) from 14 valuation models. Cautious scenario 288.70 IDR, optimistic scenario 536.17 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Budi Starch & Sweetener Tbk stock forecast for 2026?
Our models put fair value at 412.43 IDR, about +82% upside versus a price of 226.00 IDR (undervalued). Cautious scenario 288.70 IDR, optimistic scenario 536.17 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Budi Starch & Sweetener Tbk (BUDI)?
Budi Starch & Sweetener Tbk reported trailing-twelve-month revenue of about 3.4T IDR (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Budi Starch & Sweetener Tbk (BUDI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Budi Starch & Sweetener Tbk it is 412.43 IDR per share (as of Sep 24, 2026), against a price of 226.00 IDR. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Budi Starch & Sweetener Tbk stock overvalued or undervalued in 2026?
As of Sep 24, 2026, BUDI trades below its calculated fair value: price 226.00 IDR, fair value 412.43 IDR, a gap of about +82% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BUDI?
No. The price is what the market pays today (226.00 IDR); the fair value is what the company's own numbers justify (412.43 IDR). For Budi Starch & Sweetener Tbk the two are 186.43 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Budi Starch & Sweetener Tbk worth?
The market values Budi Starch & Sweetener Tbk at about 1.0T IDR (market capitalisation, as of Sep 24, 2026). Per share that is 226.00 IDR; our models calculate a fair value of 412.43 IDR per share.
What do the bullish and bearish scenarios say about BUDI?
Our models span a range for Budi Starch & Sweetener Tbk: cautious scenario 288.70 IDR, base 412.43 IDR, optimistic 536.17 IDR per share (as of Sep 24, 2026, price 226.00 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BUDI?
Budi Starch & Sweetener Tbk trades at a price-to-earnings ratio of 8.3 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 412.43 IDR is built from several models across several years. Other multiples: P/B 0.7, P/S 0.3, EV/EBITDA 3.6.
How solid is the balance sheet of Budi Starch & Sweetener Tbk (BUDI)?
Balance-sheet figures for Budi Starch & Sweetener Tbk (as of Sep 24, 2026): return on equity 7.8%, debt of 0.44 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is BUDI from its 52-week high?
Budi Starch & Sweetener Tbk trades at 226.00 IDR, about 5% below its 52-week high of 238.00 IDR and 13% above the low of 199.84 IDR (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 412.43 IDR is for.
Which stocks are comparable to Budi Starch & Sweetener Tbk?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, The Kraft Heinz Company, Foshan Haitian Flavouring and Food Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Budi Starch & Sweetener Tbk stock attractive at the current price?
The data as of Sep 24, 2026: price 226.00 IDR, calculated fair value 412.43 IDR (+82%), Quality Score 42/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BUDI calculated?
We run Budi Starch & Sweetener Tbk through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 412.43 IDR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Budi Starch & Sweetener Tbk currently trades 82 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Budi Starch & Sweetener Tbk (BUDI)?
The closing price on Sep 24, 2026 was 226.00 IDR. Our model-based fair value is 412.43 IDR, about +82% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Budi Starch & Sweetener Tbk right now?
The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (288.70 IDR). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (288.70 IDR to 536.17 IDR) leaves room in how you read the outcome.
Where does the earnings growth of Budi Starch & Sweetener Tbk (BUDI) come from?
Earnings per share at Budi Starch & Sweetener Tbk grew +13.5 % a year from 2014 to 2025. Broken into its drivers: revenue per share +4.4 %, EBIT margin +0.6 %, tax rate +4.2 %, residual (interest, one-offs) +3.8 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Budi Starch & Sweetener Tbk

How large is the market capitalisation of Budi Starch & Sweetener Tbk (BUDI)?
The market capitalisation of Budi Starch & Sweetener Tbk is 1.0T IDR (≈ $56.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Budi Starch & Sweetener Tbk (BUDI)?
The price-to-sales ratio of Budi Starch & Sweetener Tbk is 0.28 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Budi Starch & Sweetener Tbk (BUDI)?
Earnings per share at Budi Starch & Sweetener Tbk are 27.21 IDR (price ÷ EPS = P/E 8.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Budi Starch & Sweetener Tbk (BUDI)?
The net margin of Budi Starch & Sweetener Tbk is 3.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Budi Starch & Sweetener Tbk (BUDI)?
The return on equity (ROE) of Budi Starch & Sweetener Tbk is 7.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Budi Starch & Sweetener Tbk (BUDI)?
On an EBIT basis the return on assets of Budi Starch & Sweetener Tbk is 6.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Budi Starch & Sweetener Tbk (BUDI)?
The operating margin of Budi Starch & Sweetener Tbk is 7.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Budi Starch & Sweetener Tbk (BUDI)?
Revenue at Budi Starch & Sweetener Tbk is growing +29.4% versus a year earlier (3y avg −2.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Budi Starch & Sweetener Tbk (BUDI)?
Earnings per share at Budi Starch & Sweetener Tbk are growing +141% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Budi Starch & Sweetener Tbk (BUDI) generate?
The free cash flow of Budi Starch & Sweetener Tbk is −261B IDR (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Budi Starch & Sweetener Tbk (BUDI) carry?
The net debt of Budi Starch & Sweetener Tbk is 1.9T IDR (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Budi Starch & Sweetener Tbk in the live analysis

One click puts Budi Starch & Sweetener Tbk on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.